Medpace Inc.

NASDAQ: MEDP · Real-Time Price · USD
458.44
-9.56 (-2.04%)
At close: Aug 14, 2025, 3:59 PM
455.50
-0.64%
After-hours: Aug 14, 2025, 05:04 PM EDT

Medpace Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.11B 1.89B 1.46B 1.14B
Cost of Revenue
1.45B 1.36B 1.03B 814.22M
Gross Profit
656.3M 524.5M 432.44M 328.15M
Operating Income
446.87M 336.82M 278.7M 198.62M
Interest Income
25M n/a n/a n/a
Pretax Income
475.92M 335.68M 282.86M 201.85M
Net Income
404.39M 282.81M 245.37M 181.85M
Selling & General & Admin
180.18M 161.35M 131.4M 108.42M
Research & Development
n/a n/a n/a n/a
Other Expenses
29.25M 26.33M 22.34M 21.12M
Operating Expenses
209.44M 187.68M 153.74M 129.54M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
1.5M n/a n/a n/a
Cost & Expenses
1.66B 1.55B 1.18B 943.76M
Income Tax Expense
71.54M 52.87M 37.49M 20M
Shares Outstanding (Basic)
30.96M 30.72M 32.39M 35.86M
Shares Outstanding (Diluted)
32.01M 31.84M 33.67M 37.7M
EPS (Basic)
13.06 9.20 7.57 5.06
EPS (Diluted)
12.63 8.88 7.28 4.81
EBITDA
476.12M 363.15M 301.04M 219.73M
EBIT
446.87M 336.82M 278.7M 198.62M
Depreciation & Amortization
29.25M 26.33M 22.34M 21.12M